Arlington, MA, United States of America

Laura Ann McAllister

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Pawcatuck, CT (US) (2013)
  • Arlington, MA (US) (2015 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Laura Ann McAllister in Pharmaceutical Development**

Introduction

Laura Ann McAllister is a groundbreaking inventor based in Arlington, MA. With a remarkable portfolio of 13 patents, she has significantly contributed to the field of pharmaceutical innovations, particularly in the treatment of various neurological and psychological disorders. Her work at Pfizer Corporation has solidified her reputation as a key player in the industry.

Latest Patents

Among her recent innovations, one notable patent involves Piperazine azaspiro derivatives. This invention encompasses compounds that are utilized in the treatment of M4-mediated disorders, which include Alzheimer's Disease, Parkinson's Disease, schizophrenia, pain, addiction, and sleep disorders. The patent details processes for preparation and intermediates, providing valuable insights into pharmaceutical applications.

Another significant patent led by Laura focuses on 5,7-dihydro-pyrrolo-pyridine derivatives. Similar to her previous work, this invention also aims to address M4-associated disorders, offering compositions that hold promise in treating Alzheimer's Disease and schizophrenia, alongside other conditions.

Career Highlights

Laura has spent a substantial part of her career at Pfizer Corporation, where her innovative thinking has directly contributed to advancing therapeutic solutions for complex health issues. Her extensive experience and dedication to research have earned her recognition among her peers and within the wider pharmaceutical community.

Collaborations

Throughout her career, Laura has worked alongside esteemed colleagues such as Christopher Ryan Butler and Michael Aaron Brodney. These collaborations have not only enhanced her research work but have also fostered an environment of innovation and creativity, allowing for the development of potential breakthrough therapies.

Conclusion

Laura Ann McAllister’s contributions to the field of pharmaceuticals through her 13 patents demonstrate her commitment to advancing medical science. Her work reflects a deep understanding of complex disorders and a relentless pursuit of innovative solutions. As researchers continue to build upon her findings, her legacy will undoubtedly leave a lasting impact in the world of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…